Publications by authors named "James L Slack"

Claim this Profile
D
Does early chimerism testing predict outcomes after allogeneic hematopoietic stem cell transplantation?
Luke Mountjoy, Jeanne Palmer, Katie L Kunze, Nandita Khera, Lisa Z Sproat, James L Slack

Leuk Lymphoma· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes with low dose anti-thymocyte globulin in patients undergoing matched unrelated donor allogeneic hematopoietic cell transplantation.
Luke Mountjoy, Tania Jain, Katie L Kunze, Nandita Khera, Lisa Z Sproat, James L Slack

Leuk Lymphoma· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis.
Tania Jain, Katie L Kunze, Luke Mountjoy, Daniel K Partain, Heidi Kosiorek, James L Slack

Blood Cancer J· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early fluctuations in busulfan levels with therapeutic dose monitoring during allogeneic stem cell transplantation: do they matter?
Tania Jain, Katie L Kunze, Banveet K Khetarpal, Margaret R McCallen, Jeffrey A Betcher, James L Slack

Leuk Lymphoma· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of reduced intensity conditioning regimens used in patients undergoing hematopoietic stem cell transplantation for myelofibrosis.
Tania Jain, Katie L Kunze, M'hamed Temkit, Daniel K Partain, Mrinal S Patnaik, James L Slack

Bone Marrow Transplant· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single dose versus multiple doses of rituximab for preemptive therapy of Epstein-Barr virus reactivation after hematopoietic cell transplantation.
Tania Jain, Heidi E Kosiorek, Thomas E Grys, Shu Ting Kung, Vishal S Shah, James L Slack

Leuk Lymphoma· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.
Courtney D DiNardo, Eytan M Stein, Stéphane de Botton, Gail J Roboz, Jessica K Altman, James L Slack

N Engl J Med· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic stem cell transplant overcomes the adverse survival effect of very high risk and unfavorable karyotype in myelofibrosis.
Ayalew Tefferi, Daniel K Partain, Jeanne M Palmer, James L Slack, Vivek Roy

Am J Hematol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbiologic yield of bronchoalveolar lavage specimens from stem cell transplant recipients.
Kenneth K Sakata, Christine L Klassen, Kathryn B Bollin, Thomas E Grys, James L Slack

Transpl Infect Dis· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytogenetic Evolution in Myeloid Neoplasms at Relapse after Allogeneic Hematopoietic Cell Transplantation: Association with Previous Chemotherapy and Effect on Survival.
Natalie Ertz-Archambault, Heidi Kosiorek, James L Slack, Melissa L Lonzo, Patricia T Greipp

Biol Blood Marrow Transplant· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamics of leukemia stem-like cell extinction in acute promyelocytic leukemia.
Benjamin Werner, Robert E Gallagher, Elisabeth M Paietta, Mark R Litzow, Martin S Tallman, James L Slack

Cancer Res· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced toxicity conditioning and allogeneic stem cell transplantation in adults using fludarabine, carmustine, melphalan, and antithymocyte globulin: outcomes depend on disease risk index but not age, comorbidity score, donor type, or human leukocyte antigen mismatch.
James L Slack, Amylou C Dueck, Veena D Fauble, Lisa O Sproat, Craig B Reeder

Biol Blood Marrow Transplant· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic stem cell transplantation for myeloproliferative neoplasm in blast phase.
Chad Cherington, James L Slack, Jose Leis, Roberta H Adams, Craig B Reeder

Leuk Res· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group.
Martin S Tallman, Haesook T Kim, Pau Montesinos, Frederick R Appelbaum, Javier de la Serna, James L Slack

Blood· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial.
David P Steensma, Maria R Baer, James L Slack, Rena Buckstein, Lucy A Godley

J Clin Oncol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologic, and pathologic characteristics.
Aasma Shaukat, Faris Bakri, Paul Young, Theresa Hahn, Donna Ball, James L Slack

Mycopathologia· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thrombotic microangiopathy after allogeneic blood and marrow transplantation is associated with dose-intensive myeloablative conditioning regimens, unrelated donor, and methylprednisolone T-cell depletion.
Theresa Hahn, Arif Raza Alam, David Lawrence, Laurieann Ford, Maria R Baer, James L Slack

Transplantation· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Linezolid-resistant Enterococcus faecalis isolated from a cord blood transplant recipient.
Imad Dibo, Satish K Pillai, Howard S Gold, Maria R Baer, Meir Wetzler, James L Slack

J Clin Microbiol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Massive hyperdiploidy and tetraploidy in acute myelocytic leukemia and myelodysplastic syndrome.
Renuka V Iyer, Sheila N J Sait, Sei-Ichi Matsui, AnneMarie W Block, Maurice Barcos, James L Slack

Cancer Genet Cytogenet· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simvastatin-fluconazole causing rhabdomyolysis.
Aasma Shaukat, Mustafa Benekli, Georgirene D Vladutiu, James L Slack, Meir Wetzler

Ann Pharmacother· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129.
Robert E Gallagher, Beow Y Yeap, Wanli Bi, Kenneth J Livak, Nike Beaubier, James L Slack

Blood· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in the management of acute promyelocytic leukemia and other hematologic malignancies with arsenic trioxide.
James L Slack, Samuel Waxman, Guido Tricot, Martin S Tallman, Clara D Bloomfield

Oncologist· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis